Pharma Talks

Nataliya Andreychuk
  • 0.0（0）
  • マーケティング
  • アップデート：隔週

Join Nataliya Andreychuk, CEO of Viseven, on Pharma Talks – a podcast where human voices meet industry insights. Dive into engaging conversations with industry leaders, exploring the latest trends in pharma marketing, digital transformation, and AI-driven solutions. 🔗 Follow Nataliya on LinkedIn for more updates and insights: https://www.linkedin.com/in/andreychuk/ 🔗 Discover more about Viseven's digital solutions at viseven.com

  1. Pharma Talks Live from Philadelphia | AI, Omnichannel & Market Access Disruption

    4月7日

    Pharma Talks Live from Philadelphia | AI, Omnichannel & Market Access Disruption

    In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond. 👥 Guests in this episode: Rohit Khuttan — Practice Director, Everest Group On AI, Omnichannel, content as the central piece of pharma engagement, and why enterprise mindset is the #1 thing that needs to change. Ruslan Horblyuk — Chief Strategy Officer, AESARA On AI in market access, health technology assessments, trust in AI data, and whether human-in-the-loop will always be necessary. Nihar Patel — Business Development, Sun Pharma On generative, predictive and communicative AI, breaking data silos, and the three pharma areas set for the biggest disruption. Key topics covered: Is Omnichannel really a content problem, not a channel problem? How AI is changing content production and the pharma supply chain Can we trust AI data in market access decisions? Will AI replace pharma professionals — or make them smarter? The three pharma disciplines AI will disrupt first 📲 Enjoyed this episode? 👉 Like, Subscribe & hit the to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at Reuters Pharma Barcelona

    30分
  2. Pharma Talks: Building Trust in Agentic AI in Pharma

    3月27日

    Pharma Talks: Building Trust in Agentic AI in Pharma

    In this episode of Pharma Talks, Natalyia Andreychuk and Anna Shavurska explore trust in AI, especially agentic AI in pharma, the importance of women in tech, and how AI can be developed responsibly with a focus on safety, trust, and diversity. Takeaways: Trust in agentic AI and safety measures in pharma The importance of women in AI development and diversity Technical approaches to secure and reliable AI, including knowledge bases and retrieval-augmented generation Chapters 00:00 Introduction to AI Trust and Women in Tech 02:00 Understanding Agentic AI and Knowledge Base Security 03:45 Ensuring Data Privacy and Trust in Pharma AI 05:39 Technical Challenges in Visual and Text Generation 07:35 Prompt Engineering and AI Output Precision 09:50 The Importance of Women in AI Development 11:38 Historical Bias and the Need for Diversity in AI 12:39 Inspiration and Career Path in AI 13:30 Closing Remarks and Future of Women in AI

    14分
  3. Content Supply Chain in Pharma | Pharma Talks

    2月21日

    Content Supply Chain in Pharma | Pharma Talks

    Content Supply Chain in Pharma | Pharma Talks In this conversation, Nataliya Andreychuk and Prasant Vijayakumar discuss the importance of the content supply chain in the pharmaceutical industry, exploring how AI is transforming content development, the relevance of modular content, and the challenges faced in ensuring effective engagement. Takeaways Content supply chain is crucial for effective communication in pharma. AI is changing the landscape of content development. MLR processes can be streamlined to enhance efficiency. Modular content remains relevant in today's digital age. Structured data is essential for effective content management. Content velocity affects how quickly updates can be communicated. Localization is key to successful content adoption. Integration of various content formats is necessary for engagement. The future of content creation will involve more video formats. Challenging the status quo of MLR can lead to significant improvements. Chapters 00:00 Introduction to Content Supply Chain in Pharma 02:18 The Role of AI in Content Development 05:11 Modular Content: Relevance and Education 07:50 Challenges in Content Structure and Data 10:26 Content Velocity and Engagement 13:03 The Future of Content Supply Chain 15:58 Localization and Infrastructure in Content Delivery 18:50 Conclusion and Future Outlook Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/

    24分
  4. Rise of Digital Opinion Leaders in Pharma | Pharma Talks

    2月11日

    Rise of Digital Opinion Leaders in Pharma | Pharma Talks

    In this episode of PharmaTalks, Nataliya Andreychuk explores the rise of digital opinion leaders with pharma omnichannel and digital engagement expert Pavlo Klymenko. The conversation goes beyond influencers and traditional key opinion leaders, focusing on a new type of voice emerging naturally in open and social media. Clinicians who build trust, share practical experience, and engage peers and patients in a more open, continuous way. Takeaways Digital opinion leaders are more than just influencers; they provide credible medical information.There is a significant gap between guidelines and real-world practices in healthcare.Patients increasingly seek information from social media rather than healthcare professionals.Effective communication requires constant dialogue with clinicians.Digital opinion leaders can help fill the gap left by misinformation online.Pharma must adapt to the fast-paced changes in healthcare communication.Engagement with digital opinion leaders should be honest and transparent.The role of digital opinion leaders is essential for product launch readiness.Pharma companies need to invest time and resources in building relationships with digital opinion leaders.Creating reusable content for digital opinion leaders can enhance communication efficiency. **** Chapters 00:00 Introduction to Digital Opinion Leaders 01:55 The Shift from KOLs to DOLs 03:33 Understanding Pharma's Engagement with DOLs 07:18 Challenges and Opportunities in Digital Engagement 11:09 The Role of Medical Governance in DOL Engagement 15:24 Building Effective Relationships with DOLs 17:28 Practical Steps for Pharma Companies 20:20 Hot or Not: Challenging the Status Quo *** 🔗 Links for more insights: https://viseven.com/key-opinion-leaders-in-pharma/https://viseven.com/healthcare-marketing-plan-guide/https://viseven.com/patient-engagement-in-pharma/https://viseven.com/pharma-crm/https://viseven.com/mlr-review-process-in-pharma-challenges-and-solutions/https://viseven.com/digital-transformation-in-pharma/https://viseven.com/life-sciences-industry-trends-2026/Follow Viseven, Nataliya, and Pavlo in social media: https://www.linkedin.com/company/2907491 https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/pavel-klymenko-2956395/

    24分
  5. Rethinking Omnichannel Marketing in Pharma | Pharma Talks

    2月3日

    Rethinking Omnichannel Marketing in Pharma | Pharma Talks

    In this episode of PharmaTalks, Nataliya Andreychuk and Nico Renner discuss the evolving landscape of pharma marketing, particularly focusing on the concept of omnichannel marketing. They explore the challenges and misconceptions surrounding omnichannel strategies, the importance of personalization versus segmentation, and the role of AI in enhancing marketing efforts. The conversation emphasizes the need for a more human touch in marketing and practical steps that pharma teams can take to improve their strategies. Nico Renner is strictly sharing is personal views and opinion as an individual, not his current employer’s position on the discussed topics. Takeaways Omnichannel marketing is often misunderstood and overhyped. Personalization should be distinct from segmentation in marketing. The human element in marketing is crucial for effective engagement. AI can help streamline marketing processes but should focus on relevance. Pharma marketers face increasing pressure to be multifaceted experts. Segmentation can be more effective than personalization at scale. The industry needs to recalibrate its expectations from omnichannel strategies. Marketers should prioritize creating relevant content over sheer volume. The future of pharma marketing lies in understanding patient needs better. A more human touch in marketing will be increasingly valued. Chapters 00:00 Introduction to Omnichannel Marketing in Pharma 02:08 The Evolution of Pharma Marketing 04:46 Rethinking Omnichannel: Overrated or Misunderstood? 08:18 Personalization vs. Segmentation: A Misalignment? 19:22 Practical Steps for Pharma's Future 24:33 Hot or Not: Myths in Pharma Marketing 🔗 Links for more insights: https://viseven.com/omnichannel/ https://viseven.com/content-development/ https://viseven.com/difference-multichannel-omnichannel-pharma-communication-many-overlooked/ https://viseven.com/using-omnichannel-approach-to-achieve-better-hcp-engagement-how-does-it-work/ Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Follow Viseven, Nataliya, and Paul in social media: https://www.linkedin.com/company/2907491/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/nicorenner

    26分
  6. Human Element in Digital Transformation | Pharma Talks

    1月26日

    Human Element in Digital Transformation | Pharma Talks

    In this engaging conversation, Nataliya Andreychuk and Paul Tunnah discuss the evolving landscape of the pharmaceutical industry as they approach 2026. They explore the importance of digital transformation, emphasizing the need for a human-centric approach rather than a technology-first mindset. The discussion delves into the risks and rewards associated with AI in pharma, the significance of customer engagement, and the challenges of hyper-personalization versus effective segmentation. Takeaways Digital transformation must prioritize human change over technology. AI presents both risks and rewards that need careful consideration. Customer engagement strategies should focus on building trust and connection. Segmentation is crucial for effective communication in pharma. Hyper-personalization may not be the best approach for all situations. Content quality is essential to cut through the noise in marketing. Companies should embrace a mindset of continuous evolution and adaptation. Collaboration between IT and business leaders is vital for success. The future of pharma will require a balance between technology and human insight. 2026 will be a pivotal year for the pharmaceutical industry. Chapters 00:00 Introduction and Year-End Reflections 03:05 Digital Transformation and the Human Element 05:48 AI, Risk, and Reward in Pharma 08:35 Customer Engagement and the Future 11:28 Navigating AI and Content Creation 14:22 Hyper-Personalization vs. Segmentation 17:04 Hot or Not: Industry Predictions 25:52 Conclusion and Looking Ahead to 2026 Watch, listen, and reflect before you plan your 2026 strategy

    28分
  7. AI and Marketing: The Smart Shift in Pharma | Pharma Talks

    1月16日

    AI and Marketing: The Smart Shift in Pharma | Pharma Talks

    Discover how AI is reshaping pharma – from marketing automation to intelligent sales strategies – with our guest Fredrik Holmboe. Listen to the new Pharma Talks episode with Nataliya Andreychuk! Together, they explore how the role of the modern marketeer is evolving – from content creators to AI-driven orchestrators of omnichannel engagement. The conversation uncovers how AI in sales and marketing is reshaping daily operations, driving smarter decisions, and creating a seamless bridge between sales, marketing, and medical teams. Key topics explored in this episode: The shift from traditional marketing to AI and digital marketing approaches.How AI for sales and marketing empowers teams with predictive insights and real-time personalization.Practical examples of AI-driven sales enablement and content intelligence tools improving HCP engagement.Bridging organizational silos through data intelligence, automation, and AI for customer experience.Fredrik's ABC+ Content Excellence Framework – helping life science companies enhance digital engagement in pharma and ensure unified messaging across all channels.What the future holds for AI adoption in life science, pharma business transformation, and human-AI co-creation. Tune in to discover where creativity meets intelligence, and technology becomes the enabler of more meaningful healthcare communication! Find out more about ABC+ Content Excellence Framework: https://www.dualia.se/ Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert Support Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ *** 0:00 Intro 03:14 The evolving role of marketers in Pharma 06:09 Real-world applications of AI in marketing 17:17 Bridging gaps: sales, marketing, and medical collaboration 22:59 The future of marketing: orchestrating AI tools *** Follow Viseven, Nataliya, and Fredrik in social media: https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/fredrikholmboe/ *** 🔗 Links for more insights: https://viseven.com/ai-data/ https://viseven.com/healthcare-data-analytics/ https://viseven.com/ai-medical-affairs/ https://viseven.com/list-of-ai-mistakes-pharma-companies-make/

    30分
  8. Pharma 2026: Connecting AI, People, and Processes | Pharma Talks with the Viseven Team

    2025/12/30

    Pharma 2026: Connecting AI, People, and Processes | Pharma Talks with the Viseven Team

    In this episode, Viseven leaders reflect on the trends shaping the pharmaceutical industry today. The discussion focuses on how digital transformation is evolving from isolated initiatives into connected systems that support real business execution. Automation and AI are no longer optional, but their value depends on how well they are integrated into existing workflows and operating models. This episode looks ahead to what’s next for pharma and life sciences, and what it takes to operationalize AI in a way that strengthens teams rather than replaces them. Key topics explored in this episode: The pharmaceutical industry is increasingly focusing on digital transformation and automation.Companies are rationalizing their systems to integrate AI more effectively.AI should be part of the core processes, not a separate entity.People and processes are crucial for successful tech integration.2026 will see a shift from AI pilots to operationalized solutions.AI will be integrated into teams to enhance productivity.The role of professionals will evolve to be more technology-savvy and cross-functional.There are challenges in balancing AI capabilities with human creativity.The industry must adapt quickly to the changing landscape of AI.Strategic thinking in the AI era requires a new approach to roles and responsibilities.*** Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert Support Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ *** 00:00 Introduction to Pharma Talks and Team Insights 00:56 Trends in Pharma: Digital Transformation and Automation 03:04 The Role of People and Processes in Tech Integration 05:08 Forecasting 2026: Operationalizing AI in Pharma 08:27 Challenges and Opportunities in the AI Era *** Follow Viseven, Nataliya in social media: https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/

    31分
すべて見る（25）

番組について

Join Nataliya Andreychuk, CEO of Viseven, on Pharma Talks – a podcast where human voices meet industry insights. Dive into engaging conversations with industry leaders, exploring the latest trends in pharma marketing, digital transformation, and AI-driven solutions. 🔗 Follow Nataliya on LinkedIn for more updates and insights: https://www.linkedin.com/in/andreychuk/ 🔗 Discover more about Viseven's digital solutions at viseven.com

情報

  • クリエイター
    Nataliya Andreychuk
  • 配信期間
    25年 - 26年
  • エピソード
    25
  • 制限指定
    不適切な内容を含まない
  • Copyright
    © Viseven 2025
  • 番組のWebサイト
    Pharma Talks